{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2013-D-1143\" sorted by posted_date descending", "rows": [["FDA-2013-D-1143-0099", "FDA", "FDA-2013-D-1143", "Use of Nucleic Acid Tests To Reduce the Risk of Transmission of West Nile\nVirus From Living Donors of Human Cells, Tissues, and Cellular and\nTissue-Based Products; Guidance for Industry; Correction", "Notice", "Correction", "2016-09-29T04:00:00Z", 2016, 9, "2016-09-29T04:00:00Z", null, "2016-09-29T15:15:04Z", "2016-23514", 0, 0, "090000648227f819"], ["FDA-2013-D-1143-0097", "FDA", "FDA-2013-D-1143", "Use of Nucleic Acid Tests To Reduce the Risk of Transmission of West Nile\nVirus From Living Donors of Human Cells, Tissues, and Cellular and\nTissue-Based Products; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-09-13T04:00:00Z", 2016, 9, "2016-09-13T04:00:00Z", "2016-12-13T04:59:59Z", "2016-09-13T14:43:16Z", "2016-21969", 0, 0, "0900006482202771"], ["FDA-2013-D-1143-0098", "FDA", "FDA-2013-D-1143", "Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Living Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Guidance for Industry", "Other", "Guidance", "2016-09-08T04:00:00Z", 2016, 9, "2016-09-08T04:00:00Z", null, "2024-11-07T23:49:39Z", null, 1, 0, "09000064821e37f2"], ["FDA-2013-D-1143-0094", "FDA", "FDA-2013-D-1143", "Reference 6 Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus April 2008", "Supporting & Related Material", "Reference (internal unless indicated)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T20:38:59Z", null, 0, 0, "0900006481da8779"], ["FDA-2013-D-1143-0065", "FDA", "FDA-2013-D-1143", "Reference 16 Epidemic West Nile Encephalitis New York 1999 Results of a Household-based Seroepidemiological Survey", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:36:14Z", null, 0, 0, "0900006481da87fe"], ["FDA-2013-D-1143-0067", "FDA", "FDA-2013-D-1143", "Reference 18 Manifestations of West Nile Virus Neuroinvasive Diesease", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:50:18Z", null, 0, 0, "0900006481da8800"], ["FDA-2013-D-1143-0070", "FDA", "FDA-2013-D-1143", "Reference 21 West Nile Virus and Other Arboviral Diseases - United States, 2010", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:07:45Z", null, 0, 0, "0900006481da8803"], ["FDA-2013-D-1143-0068", "FDA", "FDA-2013-D-1143", "Reference 19  West Nile Virus Screening of Blood Donations and Transfusion-Associated Transmission - United States, 2003", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:55:57Z", null, 0, 0, "0900006481da8801"], ["FDA-2013-D-1143-0071", "FDA", "FDA-2013-D-1143", "Reference 22 Invasive Staphylococcus aureus Infections Associated with Pain Injections and Reuse of Single-Dose Vials - Arizona and Delaware, 2012", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:12:07Z", null, 0, 0, "0900006481da8804"], ["FDA-2013-D-1143-0075", "FDA", "FDA-2013-D-1143", "Reference 26 Risk Factors for West Nile Virus Neuroinvasive Disease, California, 2005", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:26:56Z", null, 0, 0, "0900006481da8a4a"], ["FDA-2013-D-1143-0052", "FDA", "FDA-2013-D-1143", "Reference 2 Food and Drug Administration Workshop on Development of Donor Screening Assays for West Nile Virus", "Supporting & Related Material", "Reference (internal unless indicated)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T17:49:15Z", null, 0, 0, "0900006481da8775"], ["FDA-2013-D-1143-0073", "FDA", "FDA-2013-D-1143", "Reference 24 West Nile Virus and Other Arboviral Diseases - United States, 2013", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:19:11Z", null, 0, 0, "0900006481da8806"], ["FDA-2013-D-1143-0078", "FDA", "FDA-2013-D-1143", "Reference 29 Estimated Risk of West Nile Virus Transmission Through Blood Transfusion During an Epidemic in Queens, New York City", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:39:09Z", null, 0, 0, "0900006481da8a4e"], ["FDA-2013-D-1143-0082", "FDA", "FDA-2013-D-1143", "Reference 33 Transfusion-Associated Transmission of West Nile Virus, United States 2003 through 2005", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:48:29Z", null, 0, 0, "0900006481da8a52"], ["FDA-2013-D-1143-0092", "FDA", "FDA-2013-D-1143", "Reference 43 West Nile encephalitis in 2 Hematopoietic Stem Cell Transplant Recipients: Case Series and Literature Review", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T20:11:55Z", null, 0, 0, "0900006481da8aea"], ["FDA-2013-D-1143-0090", "FDA", "FDA-2013-D-1143", "Reference 41 West Nile Virus Transmission Through Organ Transplantation in North Eastern Italy A Case Report and Implications for Pre-Procurement Screening", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T20:07:07Z", null, 0, 0, "0900006481da8885"], ["FDA-2013-D-1143-0053", "FDA", "FDA-2013-D-1143", "Reference 3 Transmission of West Nile Virus through Blood Transfusion in the United States in 2002", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T17:51:56Z", null, 0, 0, "0900006481da8776"], ["FDA-2013-D-1143-0058", "FDA", "FDA-2013-D-1143", "Reference 10 The Outbreak of West Nile Virus Infection in the New York City Area in 1999", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:11:16Z", null, 0, 0, "0900006481da87d5"], ["FDA-2013-D-1143-0076", "FDA", "FDA-2013-D-1143", "Reference 27 Centers for Disease Control and Prevention website for Surveillance Resources", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:32:00Z", null, 0, 0, "0900006481da8a4c"], ["FDA-2013-D-1143-0081", "FDA", "FDA-2013-D-1143", "Reference 32 Acute Flaccid Paralysis Syndrome Associated with West Nile Virus Infection \u2014 Mississippi and Louisiana, July\u2013August 2002", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:45:51Z", null, 0, 0, "0900006481da8a51"], ["FDA-2013-D-1143-0093", "FDA", "FDA-2013-D-1143", "Reference 44 West Nile virus infection transmitted by granulocyte transfusion", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T20:14:18Z", null, 0, 0, "0900006481da8aeb"], ["FDA-2013-D-1143-0062", "FDA", "FDA-2013-D-1143", "List of References", "Supporting & Related Material", "List", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:27:31Z", null, 0, 0, "0900006481da8773"], ["FDA-2013-D-1143-0056", "FDA", "FDA-2013-D-1143", "Reference 7 Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion", "Supporting & Related Material", "Reference (internal unless indicated)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T17:59:45Z", null, 0, 0, "0900006481da877b"], ["FDA-2013-D-1143-0060", "FDA", "FDA-2013-D-1143", "Reference 12 An Update on the Potential of North American Mosquitoes Diptera: Culicidae to Transmit West Nile Virus", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:15:43Z", null, 0, 0, "0900006481da87d9"], ["FDA-2013-D-1143-0069", "FDA", "FDA-2013-D-1143", "Reference 20 Surveillance for Human West Nile Virus Disease - United States, 1999-2008", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:05:52Z", null, 0, 0, "0900006481da8802"], ["FDA-2013-D-1143-0089", "FDA", "FDA-2013-D-1143", "Reference 40 Absence of Neuroinvasive Disease in a Liver Transplant Recipient Who Acquired West Nile Virus (WNV) Infection from the Organ Donor and Who Received WNV Antibodies Prophylactically", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T20:04:28Z", null, 0, 0, "0900006481da8884"], ["FDA-2013-D-1143-0051", "FDA", "FDA-2013-D-1143", "Reference 1 Food and Drug Administration, Guidance for Industry  Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products", "Supporting & Related Material", "Reference (internal unless indicated)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T17:47:11Z", null, 0, 0, "0900006481da8774"], ["FDA-2013-D-1143-0064", "FDA", "FDA-2013-D-1143", "Reference 15 Epidemiology and Transmission Dynamics of West Nile Virus Disease", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:32:45Z", null, 0, 0, "0900006481da87dc"], ["FDA-2013-D-1143-0085", "FDA", "FDA-2013-D-1143", "Reference 36 West Nile Transmission Via Organ Transplantation and Blood Transfusion-Louisiana 2008", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:55:07Z", null, 0, 0, "0900006481da8880"], ["FDA-2013-D-1143-0086", "FDA", "FDA-2013-D-1143", "Reference 37 Organ Procurement Transplantation Network Guidance for Identifying Risk Factors for West Nile Virus during Evaluation of Potential Living Donors", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:58:45Z", null, 0, 0, "0900006481da8881"], ["FDA-2013-D-1143-0057", "FDA", "FDA-2013-D-1143", "Reference 8 West Nile Virus Workshop: Scientific Considerations for Tissue Donors", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:08:18Z", null, 0, 0, "0900006481da87d3"], ["FDA-2013-D-1143-0059", "FDA", "FDA-2013-D-1143", "Reference 11 West Nile Fever", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:13:26Z", null, 0, 0, "0900006481da87d6"], ["FDA-2013-D-1143-0088", "FDA", "FDA-2013-D-1143", "Reference 39 West Nile Virus Infections in Organ Transplant Recipients-New York and Pennsylvania, August - September 2005", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T20:02:09Z", null, 0, 0, "0900006481da8883"], ["FDA-2013-D-1143-0049", "FDA", "FDA-2013-D-1143", "Use of Nucleic Acid Tests To Reduce the Risk of Transmission of West Nile\nVirus From Living Donors of Human Cells, Tissues, and Cellular and\nTissue-Based Products; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-12-15T05:00:00Z", 2015, 12, "2015-12-15T05:00:00Z", "2016-03-15T03:59:59Z", "2016-08-31T16:43:07Z", "2015-31405", 0, 0, "0900006481da74bd"], ["FDA-2013-D-1143-0050", "FDA", "FDA-2013-D-1143", "Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Living Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Draft Guidance for Industry", "Other", "Guidance", "2015-12-15T05:00:00Z", 2015, 12, "2015-12-15T05:00:00Z", null, "2024-11-11T21:14:43Z", null, 1, 0, "0900006481da8904"], ["FDA-2013-D-1143-0061", "FDA", "FDA-2013-D-1143", "Reference 13 Indigenous Wild Birds of the Nile Delta as Potential West Nile Virus Circulating Reservoirs", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:17:59Z", null, 0, 0, "0900006481da87da"], ["FDA-2013-D-1143-0063", "FDA", "FDA-2013-D-1143", "Reference 14 Serologic Evidence for West Nile Virus Infection in BIrds in the New York City Vicinity During an Outbreak in 1999", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:30:35Z", null, 0, 0, "0900006481da87db"], ["FDA-2013-D-1143-0066", "FDA", "FDA-2013-D-1143", "Reference 17 West Nile Virus Neuroinvasisve Disease", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T18:47:08Z", null, 0, 0, "0900006481da87ff"], ["FDA-2013-D-1143-0077", "FDA", "FDA-2013-D-1143", "Reference 28 Centers for Disease Control and Prevention website for West Nile Virus", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:33:46Z", null, 0, 0, "0900006481da8a4d"], ["FDA-2013-D-1143-0080", "FDA", "FDA-2013-D-1143", "Reference 31 West Nile Virus Infections Projected From Blood Donor Screening Data, United States, 2003", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:43:16Z", null, 0, 0, "0900006481da8a50"], ["FDA-2013-D-1143-0079", "FDA", "FDA-2013-D-1143", "Reference 30 Associations Between West Nile Virus Infection and Symptoms Reported by Blood Donors Identified Through Nucleic Acid Test Screening", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:41:19Z", null, 0, 0, "0900006481da8a4f"], ["FDA-2013-D-1143-0084", "FDA", "FDA-2013-D-1143", "Reference 35 West Nile Virus Transmission Through Blood Transfusion - South Dakota, 2006", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:56:09Z", null, 0, 0, "0900006481da887f"], ["FDA-2013-D-1143-0055", "FDA", "FDA-2013-D-1143", "Reference 5 Transfusion Transmitted Infections in Solid Organ Transplantation", "Supporting & Related Material", "Reference (internal unless indicated)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T17:56:11Z", null, 0, 0, "0900006481da8778"], ["FDA-2013-D-1143-0095", "FDA", "FDA-2013-D-1143", "Reference 9 Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus October 2013", "Supporting & Related Material", "Reference (internal unless indicated)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T20:40:09Z", null, 0, 0, "0900006481da87d4"], ["FDA-2013-D-1143-0074", "FDA", "FDA-2013-D-1143", "Reference 25 World Health Organization Media Centre West Nile Virus Fact Sheet", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:21:09Z", null, 0, 0, "0900006481da8807"], ["FDA-2013-D-1143-0087", "FDA", "FDA-2013-D-1143", "Reference 38 Update Investigations of West Nile Virus Infections in Recipients of Organ Transplantation and Blood Transfusion", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T20:00:28Z", null, 0, 0, "0900006481da8882"], ["FDA-2013-D-1143-0083", "FDA", "FDA-2013-D-1143", "Reference 34 Heat Illness and Deaths - New York City, 2000-2011", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:50:15Z", null, 0, 0, "0900006481da8a53"], ["FDA-2013-D-1143-0091", "FDA", "FDA-2013-D-1143", "Reference 42 Fatal West Nile Virus Encephalitis in a Renal Transplant Recipient", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T20:09:22Z", null, 0, 0, "0900006481da8ae9"], ["FDA-2013-D-1143-0054", "FDA", "FDA-2013-D-1143", "Reference 4 Transmission of West Nile Virus from an Organ Donor to Four Transplant Recipients", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T17:54:12Z", null, 0, 0, "0900006481da8777"], ["FDA-2013-D-1143-0072", "FDA", "FDA-2013-D-1143", "Reference 23 West Nile Virus and Other Arboviral Diseases  - United States, 2012", "Supporting & Related Material", "Reference (external attachments)", "2015-12-15T05:00:00Z", 2015, 12, null, null, "2015-12-15T19:17:28Z", null, 0, 0, "0900006481da8805"], ["FDA-2013-D-1143-0002", "FDA", "FDA-2013-D-1143", "Draft Guidance for Industry:  Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus From Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products", "Other", "Guidance", "2013-10-24T04:00:00Z", 2013, 10, "2013-10-24T04:00:00Z", null, "2024-11-12T05:20:29Z", null, 1, 0, "090000648145d7aa"], ["FDA-2013-D-1143-0001", "FDA", "FDA-2013-D-1143", "Draft Guidance for Industry:  Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus From Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products; Availability", "Notice", "Notice of Availability", "2013-10-24T04:00:00Z", 2013, 10, "2013-10-24T04:00:00Z", "2014-01-23T04:59:59Z", "2014-03-28T01:01:32Z", "2013-24940", 0, 0, "090000648145d509"]], "truncated": false, "filtered_table_rows_count": 52, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2013-D-1143"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2013-D-1143", "results": [{"value": "FDA", "label": "FDA", "count": 52, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2013-D-1143", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 45, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2013-D-1143", "results": [{"value": 2015, "label": 2015, "count": 47, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&posted_year=2015", "selected": false}, {"value": 2016, "label": 2016, "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&posted_year=2016", "selected": false}, {"value": 2013, "label": 2013, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&posted_year=2013", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-D-1143&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 2904.063298017718, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}